Renascience Inc. (TYO:4889)
Japan · Delayed Price · Currency is JPY 1,103.00
-27.00 (-2.39%)
Oct 2, 2026, 3:30 PM JST
Renascience Revenue
Renascience had revenue of 10.00M JPY in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 68.00M, down -33.33% year-over-year. In the fiscal year ending March 31, 2026, Renascience had annual revenue of 68.00M, down -48.48%.
Revenue
68.00M
Revenue Growth
-33.33%
P/S Ratio
223.47
Revenue / Employee
n/a
Employees
3
Market Cap
15.20B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 68.00M | -64.00M | -48.48% |
| Mar 31, 2025 | 132.00M | -62.00M | -31.96% |
| Mar 31, 2024 | 194.00M | 94.00M | 94.00% |
| Mar 31, 2023 | 100.00M | -39.00M | -28.06% |
| Mar 31, 2022 | 139.00M | -70.00M | -33.49% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ohki Healthcare Holdings | 363.02B |
| Qol Holdings | 292.95B |
| Cawachi | 285.45B |
| YAKUODO HOLDINGS | 168.44B |
| Medical System Network | 134.23B |
| Satudora Holdings | 100.33B |
| Pharmarise Holdings | 70.00B |
| Astena Holdings | 67.21B |